ATE307899T1 - Neue methode zum auffindenund bewerten biologisch aktiver moleküle - Google Patents

Neue methode zum auffindenund bewerten biologisch aktiver moleküle

Info

Publication number
ATE307899T1
ATE307899T1 AT95941352T AT95941352T ATE307899T1 AT E307899 T1 ATE307899 T1 AT E307899T1 AT 95941352 T AT95941352 T AT 95941352T AT 95941352 T AT95941352 T AT 95941352T AT E307899 T1 ATE307899 T1 AT E307899T1
Authority
AT
Austria
Prior art keywords
evaluating
finding
biologically active
new method
active molecules
Prior art date
Application number
AT95941352T
Other languages
English (en)
Inventor
Stuart L Schreiber
Gerald R Crabtree
Dennis A Holt
Mark J Zoller
Original Assignee
Ariad Gene Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27406888&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE307899(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ariad Gene Therapeutics Inc filed Critical Ariad Gene Therapeutics Inc
Application granted granted Critical
Publication of ATE307899T1 publication Critical patent/ATE307899T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT95941352T 1994-11-01 1995-11-01 Neue methode zum auffindenund bewerten biologisch aktiver moleküle ATE307899T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33299594A 1994-11-01 1994-11-01
US40080095A 1995-03-07 1995-03-07
US48028695A 1995-06-07 1995-06-07
PCT/US1995/014177 WO1996013613A1 (en) 1994-11-01 1995-11-01 New method for identifying and evaluating biologically active molecules

Publications (1)

Publication Number Publication Date
ATE307899T1 true ATE307899T1 (de) 2005-11-15

Family

ID=27406888

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95941352T ATE307899T1 (de) 1994-11-01 1995-11-01 Neue methode zum auffindenund bewerten biologisch aktiver moleküle

Country Status (6)

Country Link
EP (1) EP0787207B1 (de)
AT (1) ATE307899T1 (de)
AU (1) AU4279996A (de)
DE (1) DE69534551T2 (de)
ES (1) ES2250978T3 (de)
WO (1) WO1996013613A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2252886C (en) * 1996-04-26 2008-02-12 Massachusetts Institute Of Technology Three-hybrid screening assay
DE19741738A1 (de) 1997-09-22 1999-03-25 Hoechst Ag Linker-Nucleosid, seine Herstellung und Verwendung
DE19741739B4 (de) 1997-09-22 2006-04-27 Nanogen Recognomics Gmbh Supramolekulares Paarungssystem, dessen Herstellung und Verwendung
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6919178B2 (en) 2000-11-21 2005-07-19 Sunesis Pharmaceuticals, Inc. Extended tethering approach for rapid identification of ligands
US6998233B2 (en) 1998-06-26 2006-02-14 Sunesis Pharmaceuticals, Inc. Methods for ligand discovery
US6335155B1 (en) 1998-06-26 2002-01-01 Sunesis Pharmaceuticals, Inc. Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
WO2001035978A1 (en) 1999-11-19 2001-05-25 The Board Of Trustees Of The Leland Stanford Junior University Targeted bifunctional molecules and therapies based thereon
US6887842B1 (en) 1999-11-19 2005-05-03 The Board Of Trustees Of The Leland Stanford Junior University Modulating a pharmacokinetic property of a drug by administering a bifunctional molecule containing the drug
US7220552B1 (en) 1999-11-19 2007-05-22 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and their use in the disruption of protein-protein interactions
ATE497603T1 (de) * 2001-03-02 2011-02-15 Gpc Biotech Ag Drei-hybrid-assaysystem
EP1996732A4 (de) 2006-03-02 2010-03-31 Uab Research Foundation Erkennung und behandlung von sowie entdeckung von heilmitteln gegen mycobakterielle krankheiten
US10634668B2 (en) 2012-09-13 2020-04-28 Takara Bio Usa, Inc. Modifiable chemical inducers of proximity and methods of using the same
EP3008192B1 (de) 2013-06-11 2019-07-17 Takara Bio USA, Inc. Proteinangereicherte mikrovesikel und verfahren zur herstellung und verwendung davon
CA3099155A1 (en) 2018-05-14 2019-11-21 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
CA3138197A1 (en) 2019-05-14 2020-11-19 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
EP4058464A1 (de) 2019-11-13 2022-09-21 Nuvation Bio Inc. Auf nuklearhormonrezeptor abzielende antikrebsverbindungen
MX2023011241A (es) 2021-03-23 2023-10-03 Nuvation Bio Inc Compuestos dirigidos a receptores de hormonas nucleares contra el cancer.
JP2024516024A (ja) 2021-05-03 2024-04-11 ニューベイション・バイオ・インコーポレイテッド 抗がん核内ホルモン受容体標的化化合物

Also Published As

Publication number Publication date
EP0787207A1 (de) 1997-08-06
DE69534551D1 (de) 2005-12-01
WO1996013613A1 (en) 1996-05-09
AU4279996A (en) 1996-05-23
ES2250978T3 (es) 2006-04-16
DE69534551T2 (de) 2006-06-22
EP0787207A4 (de) 1999-12-01
EP0787207B1 (de) 2005-10-26

Similar Documents

Publication Publication Date Title
ATE307899T1 (de) Neue methode zum auffindenund bewerten biologisch aktiver moleküle
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
ATE394484T1 (de) Smad 6 und dessen anwendungen
DE69638032D1 (de) Modifiziertes bacillus thuringiensis gen zur kontrolle von lepidoptera in pflanzen
IL131016A0 (en) Selection of proteins using rna-protein fusions
ATE319823T1 (de) Bmp-12, bmp-13 und diese enthaltende sehne- induzierende zusammensetzungen
BG102071A (en) Minor molecule inhibitors of rotamase enzymic activity
ATE315652T1 (de) Polypeptidzusammensetzungen von bacillus thuringiensis cryet70 die für diabrotica insekten toxisch sind, und methoden zur dessen verwendung
ES2162132T3 (es) Polimerasa de adn termoestable procedente de thermoanaerobacter thermohydrosulfuricus y enzimas mutantes, de actividad exonucleasa suprimida asi obtenidos.
EP1025204A4 (de) Methoden und materialien zur kultivierung von von primaten abgeleiteten primordialen stammzellen
ATE253637T1 (de) Methoden zur erhöhung der biologischen aktivität von chemokinen
ATE278951T1 (de) Bakterielles multi-hybrid system und anwendungen dafür
DE69737651D1 (de) Cortistatin: neuropeptide, zusammensetzungen und methoden
WO1999000407A3 (en) Improved bacillus thuringiensis toxin
TR199802019T2 (xx) Terap�tik amidleri stereoselektif olarak haz�rlamak i�in enzimatik y�ntem.
DE60029748D1 (de) Biologische bekämpfung von nematoden
DE3855827D1 (de) Bacillus thuringiensis p-2-toxingen, protein und damit in zusammenhang stehende insektizide zusammensetzungen
DK0708831T4 (da) Celledensitetsforstærkede proteintyrosinphosphataser
DK0512087T3 (da) Fremgangsmåde til reaktivering af denaturerede proteiner
DE122006000019I2 (de) Methode zur reinigung von keratinocyten-wachstumsfaktoren
ATE254662T1 (de) Vektoren zum einschaeuse von dns in mykobakterien und verwendung dieser bakterien als impfstoffe
DE69836634D1 (de) Chlamyidia trachomatis spezifische peptiden und deren anwendung im nachweisverfahren
EA199900387A1 (ru) Полипептиды, содержащие домены протеина gax, участвующие в подавлении транскрипции и/или взаимодействующие с другими протеинами, соответствующие нуклеиновые кислоты и их применение
ATE309371T1 (de) Protein mit dnase-aktivität
DE69838459D1 (de) Für den licht-überempfinlichkeitsphaenotyp kodierende nukleotidsequenzen von tomaten, dadurch kodierte proteine und deren verwendungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0787207

Country of ref document: EP